Suppr超能文献

患者参与输血决策可能会使患者血液管理实践变得更好或更糟。

Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse.

机构信息

Galilee Medical Center, Nahariya, Israel.

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

出版信息

Acta Haematol. 2022;145(1):5-8. doi: 10.1159/000518947. Epub 2021 Sep 15.

Abstract

BACKGROUND

Red blood cell transfusion (RBCT) is a therapeutic procedure with important and undesirable secondary effects. Inappropriate overuse of RBCT is significant, and a significant percentage of physicians prescribe RBCT unnecessarily. Patient involvement in treatment decision-making is poor worldwide. Shared (with the patient) transfusion decision-making (TrDM) can temper a "quick finger on the trigger" of blood transfusion (BT). The objective of this study was to determine patients' preferences surrounding their involvement in the TrDM process as well as physicians' willingness to involve the patient in TrDM. The study also determined the role of patient age, gender, ethnicity, and schooling years in the TrDM process.

METHODS

This cross-sectional study was conducted in a variety of departments, with 123 patients over 18 years old, who received a BT for the first time. The patients completed an anonymous questionnaire which included demographic characteristics (age, gender, ethnicity, and schooling years) and 2 questions linked to potential willingness to participate in the decision to transfuse.

RESULTS

The questionnaire response rate was 100%. The data showed that 60% of patients (especially younger patients), independent of ethnicity, preferred a passive role in TrDM and 40% preferred to share the decision.

CONCLUSIONS

The majority of patients, especially younger patients, prefer a passive role in TrDM, possibly due to insufficient information about the need for BT and its significance. We feel that active involvement on the part of the patient can provoke a more judicious thought process about the real need of BT on the part of the physician and have a positive influence on patient blood management.

摘要

背景

红细胞输血(RBCT)是一种具有重要且不良副作用的治疗程序。RBCT 的不适当过度使用是显著的,并且相当一部分医生不必要地开具 RBCT。全球范围内患者在治疗决策中的参与度都较差。与患者共同做出输血决策(TrDM)可以缓和输血(BT)的“快速触发”。本研究的目的是确定患者对参与 TrDM 过程的偏好,以及医生愿意让患者参与 TrDM。该研究还确定了患者年龄、性别、种族和受教育年限在 TrDM 过程中的作用。

方法

这是一项横断面研究,在多个科室进行,共有 123 名年龄在 18 岁以上的首次接受 BT 的患者参与。患者填写了一份匿名问卷,其中包括人口统计学特征(年龄、性别、种族和受教育年限)以及与潜在参与输血决策意愿相关的 2 个问题。

结果

问卷的回复率为 100%。数据显示,60%的患者(尤其是年轻患者),无论种族如何,在 TrDM 中更倾向于被动参与,而 40%的患者则更倾向于共同决策。

结论

大多数患者,尤其是年轻患者,在 TrDM 中更倾向于被动参与,这可能是由于他们对 BT 的必要性及其意义缺乏足够的了解。我们认为,患者的积极参与可以促使医生更审慎地思考 BT 的真正需求,并对患者的血液管理产生积极影响。

相似文献

本文引用的文献

6
Shared decision making: Concepts, evidence, and practice.共同决策:概念、证据与实践。
Patient Educ Couns. 2015 Oct;98(10):1172-9. doi: 10.1016/j.pec.2015.06.022. Epub 2015 Jul 15.
8
Clinical decision-making: Patients' preferences and experiences.临床决策:患者的偏好与体验
Patient Educ Couns. 2007 Feb;65(2):189-96. doi: 10.1016/j.pec.2006.07.007. Epub 2006 Sep 7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验